Stay updated with breaking news from Michaelj Birrer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Using a novel proteogenomic strategy and a variety of machine learning tools, investigators from the Icahn School of Medicine at Mount Sinai and colleagues have identified a 64-protein signature that may predict a subset of ovarian cancer patients who are unlikely to respond to chemotherapy.
New York, NY (PRWEB) August 03, 2023 -- New York, NY (August 3, 2023)—Using a novel proteogenomic strategy and a variety of machine learning tools,
Michael J. Birrer, MD, PhD, highlights the effect of improved molecular characterization in endometrial cancer, the clinical significance of the KEYNOTE-775 trial, and recent changes in the frontline treatment landscape in advanced endometrial cancer.
Money from the cannabis privilege tax will now be used to address food insecurity and public health needs.
Press release content from Business Wire. The AP news staff was not involved in its creation.